Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 12, 2016 - Issue 9
Submit an article Journal homepage
941
Views
0
CrossRef citations to date
0
Altmetric
Research Papers

Immunogenicity and immunization costs of adjuvanted versus non-adjuvanted hepatitis B vaccine in chronic kidney disease patients

Alba VilajeliuDepartment of Preventive Medicine and Epidemiology, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain;ISGlobal, Barcelona Ctr. Int. Health Res. (CRESIB), Hospital Clínic - Universitat de Barcelona, Barcelona, Spain
,
Víctor-Guillermo SequeraDepartment of Preventive Medicine and Epidemiology, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain;ISGlobal, Barcelona Ctr. Int. Health Res. (CRESIB), Hospital Clínic - Universitat de Barcelona, Barcelona, SpainCorrespondence[email protected]
,
Alberto L. García-BasteiroISGlobal, Barcelona Ctr. Int. Health Res. (CRESIB), Hospital Clínic - Universitat de Barcelona, Barcelona, Spain;Centro de Investigação em Saúde de Manhiça (CISM), Maputo, Mozambique;Amsterdam Institute for Global Health and Development (AIGHD), Amsterdam, The Netherlands
,
Elisa SicuriISGlobal, Barcelona Ctr. Int. Health Res. (CRESIB), Hospital Clínic - Universitat de Barcelona, Barcelona, Spain;Department of Infectious Disease Epidemiology, Health Economics Group, School of Public Health, Imperial College London, London, UK
,
Marta AldeaDepartment of Preventive Medicine and Epidemiology, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain;ISGlobal, Barcelona Ctr. Int. Health Res. (CRESIB), Hospital Clínic - Universitat de Barcelona, Barcelona, Spain
,
César VelascoDepartment of Preventive Medicine and Epidemiology, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain;ISGlobal, Barcelona Ctr. Int. Health Res. (CRESIB), Hospital Clínic - Universitat de Barcelona, Barcelona, Spain
&
José M. BayasDepartment of Preventive Medicine and Epidemiology, Hospital Clínic - Universitat de Barcelona, Barcelona, Spain;ISGlobal, Barcelona Ctr. Int. Health Res. (CRESIB), Hospital Clínic - Universitat de Barcelona, Barcelona, Spain
 show all
Pages 2317-2321 | Received 21 Dec 2015, Accepted 17 Mar 2016, Published online: 08 Jul 2016

References

  • García-Agudo R, Aoufi Rabih S, Araque Torres P, Dolores Fraga Fuentes M, Carlos Valenzuela Gámez J, Mancha Ramos J, María Tenías Burillo J. Efficacy of a hepatitis B vaccination schedule with two cycles of four double doses of conventional vaccine and four doses of adjuvanted vaccine in chronic kidney disease patients evaluated for renal transplantation. Transplant Proc 2012; 44:2532-4; PMID:23146445; http://dx.doi.org/10.1016/j.transproceed.2012.09.046
  • Burdick R, Bragg-Gresham J, Woods J, Hedderwick S, Kurokawa K, Combe C, Saito A, LaBrecjque J, Port F, Young E. Patterns of hepatitis B prevalence and seroconversion in hemodialysis units from three continents : The DOPPS. Kidney Int 2003; 63:2222-9; PMID:12753311; http://dx.doi.org/10.1046/j.1523-1755.2003.00017.x
  • Thompson ND, Perz JF, Moorman AC, Holmberg SD. Nonhospital health care-associated hepatitis B and C virus transmission: United States, 1998–2008. Ann Intern Med 2009; 150:33-9; PMID:19124818; http://dx.doi.org/10.7326/0003-4819-150-1-200901060-00007
  • Finelli L, Miller JT, Tokars JI, Alter MJ, Arduino MJ. National surveillance of dialysis-associated diseases in the United States, 2002. Semin Dial 2005; 18:52-61; PMID:15663766; http://dx.doi.org/10.1111/j.1525-139X.2005.18108.x
  • Advisory Committee on Immunization Practices (ACIP). December 2012 [Internet]. Guidel. Vaccinating. Kidney Dial. Patients Patients with Chronic Kidnewy Dis 2012; :1-12. Available from: http://www.cdc.gov/vaccines/pubs/downloads/dialysis-guide-2012.pdf
  • Martin P, Friedman LS. Chronic viral hepatitis and the management of chronic renal failure. Kidney Int 1995; 47:1231-41; PMID:7637252; http://dx.doi.org/10.1038/ki.1995.177
  • Agencia Española de Medicamentos y Productos Sanitarios (AEMPS). Ficha Técnica Engerix-B. [Internet]. 2012; Available from: http://www.aemps.gob.es/cima/fichasTecnicas.do?d-1338201-e=3&6578706f7274=1&met-odo=buscar&metodo=buscar&especial-idad=FENDRIX
  • Grzegorzewska AE. Hepatitis B vaccination in chronic kidney disease: review of evidence in non-dialyzed patients. Hepat Mon 2012; 12:e7359; PMID:23326280; http://dx.doi.org/10.5812/hepatmon.7359
  • European Medicines Agency (EMA). European Public Reports (EPARs) for authorized medical products for human use. Fendrix. [Internet]. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Summary_for_the_public/human/0005-50/WC500021703.pdf
  • Beran J. Safety and immunogenicity of a new hepatitis B vaccine for the protection of patients with renal insufficiency including pre-haemodialysis and haemodialysis patients Safety and immunogenicity of a new hepatitis B vaccine for the protection of patients wit. Expert Opin Biol Ther 2008; 8:235-47; PMID:18194079; http://dx.doi.org/10.1517/14712598.8.2.235
  • Tong NKC, Beran J, Kee SA, Miguel JL, Sánchez C, Bayas JM, Vilella A, de Juanes JR, Arrazola P, Calbo-Torrecillas F, et al. Immunogenicity and safety of an adjuvanted hepatitis B vaccine in pre-hemodialysis and hemodialysis patients. Kidney Int 2005; 68:2298-303; PMID:16221232; http://dx.doi.org/10.1111/j.1523-1755.2005.00689.x
  • Kong NCT, Beran J, Kee SA, Miguel JL, Sánchez C, Bayas JM, Vilella A, Calbo-Torrecillas F, López de Novales E, Srinivasa K, et al. A new adjuvant improves the immune response to hepatitis B vaccine in hemodialysis patients. Kidney Int 2008; 73:856-62; PMID:18160963; http://dx.doi.org/10.1038/sj.ki.5002725
  • Surquin M, Tielemans C, Nortier J, Jadoul M, Peeters P, Ryba M, Roznovsky L, Domán J, Barthelemy X, Crasta PD, et al. Anti-HBs antibody persistence following primary vaccination with an investigational AS02(v)-adjuvanted hepatitis B vaccine in patients with renal insufficiency. Hum Vaccin 2011; 7:913-8; PMID:21892006; http://dx.doi.org/10.4161/hv.7.9.16225
  • Watson B, West DJ, Chilkatowsky A, Piercy S, Ioli VA. Persistence of immunologic memory for 13 years in recipients of a recombinant hepatitis B vaccine. Vaccine 2001; 19:3164-8; PMID:11312012; http://dx.doi.org/10.1016/S0264-410X(01)00019-6
  • Melappioni M, Baldassari M, Baldini S, Radicioni R, Panichi N. Use of immunomodulators (thymopentine) in hepatitis B vaccine in elderly patients undergoing chronic hemodialysis. Nephron 1992; 61:358-9; PMID:1386910; http://dx.doi.org/10.1159/000186942
  • Pichichero ME. Improving vaccine delivery using novel adjuvant systems. Hum Vaccin 2008; 4:262-70; PMID:18398303; http://dx.doi.org/10.4161/hv.4.4.5742
  • Departament de Salut. Generalitat de Catalunya. Precios oficiales concursos Vacuna Hepatitis B. Barcelona: 2014.
  • Hospital Clínic de Barcelona. Tarifario Hospital Clínic de Barcelona. Barcelona: 2012.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.